Brief introduction of Guangzhou Langsheng Pharmaceutical Co., Ltd.

Over the years, the company has always adhered to the pharmaceutical concept of "innovation first-every drug research needs innovation" and made unremitting efforts in the long-term research and development of new products. By constantly improving the shortcomings of the existing drugs, optimizing the drug use scheme and finding new chemical monomers, we have successfully developed a number of products with independent intellectual property rights in birth control, anti-tumor drugs and drugs for severe infections, and achieved international leading technological advantages. The newly developed levonorgestrel enteric-coated tablets, the world's first enteric-coated emergency contraceptive, have obtained national patents and patent protection, and have been approved as OTC Class A drugs. In strict accordance with the regulations and requirements of the World Health Organization (WHO), the company invested in the construction of GMP production workshop and experimental complex building (equipped with large modern laboratories), with complete production facilities. Strict quality control system is implemented in the production process, from raw material procurement to product delivery, from production operation to finished product inspection, all of which are strictly operated and inspected by experienced production and inspection technicians at all levels.

In brand marketing, the company adheres to the efficient strategy of "small team, big market" and gradually increases the market share of products. In the construction of corporate culture, we uphold the core concept of "value, efficiency, safety and pleasure". In team building, we pay attention to team building and communication, and strive to build a harmonious, efficient, dedicated and innovative R&D team. In employee management, we should actively create a humanized and democratic working atmosphere and establish a phased development vision and corresponding echelon growth model for all employees. With the organic combination of technology, market and products, Langsheng Pharmaceutical has gradually embarked on the road of rapid development and become a professional pharmaceutical enterprise integrating R&D, family planning drug production and sales in South China.

Langsheng Pharmaceutical Co., Ltd. was supported by the National Innovation Fund in the process of developing levonorgestrel enteric-coated tablets in Mei Dan. In addition to Mei Dan levonorgestrel enteric-coated tablets, there are many products under development and production, and new drugs will be listed every year in the future. Focusing on birth control and technological innovation in the pharmaceutical field is becoming the basic enterprise development goal of Langsheng Pharmaceutical.